Short Interest in bioMérieux S.A. (OTCMKTS:BMXMF) Increases By 43.1%

bioMérieux S.A. (OTCMKTS:BMXMF) was the recipient of a large growth in short interest in February. As of February 28th, there was short interest totalling 154,600 shares, a growth of 43.1% from the February 13th total of 108,000 shares. Currently, 0.1% of the company’s shares are short sold. Based on an average daily volume of 1,300 shares, the days-to-cover ratio is currently 118.9 days.

bioMérieux Price Performance

BMXMF stock opened at $123.74 on Monday. bioMérieux has a one year low of $93.50 and a one year high of $126.64. The firm has a 50-day moving average of $117.41 and a two-hundred day moving average of $113.29. The company has a quick ratio of 1.20, a current ratio of 2.21 and a debt-to-equity ratio of 0.10.

About bioMérieux

bioMérieux SA develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries.